Table 4 Descriptive statistics of clinical parameters : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
Table 4 Descriptive statistics of clinical parameters : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
author: Diederik F M Hentenaar, Yvonne C M De Waal, Hans Strooker, Henny J A Meijer, Arie-Jan Van Winkelhoff, Gerry M Raghoebar | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
| Control | Test | ||||
|---|---|---|---|---|---|
| T0 (n = 22) | T3 (n = 20) | T0 (n = 31) | T3 (n = 30) | ||
| Plaque |
% of sites (SD) % of implants (n) |
4.5 (12.5) 13.6 (3) |
10.0 (18.8) 25.0 (5) |
4.0 (9.3) 16.1 (5) |
2.5 (7.6) 9.7 (3) |
| BoP |
% of sites (SD) % of implants (n) |
86.4 (18.5) 100 (22) |
28.8 (35.6) 50 (10) |
66.1 (29.3) 96.8 (30) |
39.2 (31.3) 76.7 (23) |
| SoP |
% of sites (SD) % of implants (n) |
22.7 (24.3) 54.5 (12) |
5.0 (15.4) 10.0 (2) |
30.7 (20.1) 80.6 (25) |
8.3 (20.1) 20.0 (6) |
| Mean PPD | Mean (SD) | 5.3 (1.1) | 3.5 (1.5) | 5.2 (1.1) | 4.1 (1.6) |
| PPD ≥5 mm |
% of sites (SD) % of implants (n) |
67.1 (26.0) 100 (22) |
18.8 (30.2) 35.0 (7) |
61.3 (22.2) 100 (31) |
28.3 (33.9) 46.7 (14) |
| PPD ≥6 mm |
% of sites (SD) % of implants (n) |
50.0 (27.8) 100 (22) |
12.5 (26.3) 25.0 (5) |
46.8 (26.4) 90.3 (28) |
24.2 (33.1) 40.0 (12) |
| PPD ≥5 mm + BoP/SoP (same site) |
% of sites (SD) % of implants (n) % of patients (n) |
65.9 (26.2) 100 (22) 100 (14/14) |
12.5 (25.0) 25.0 (5) 33.3 (4/12) |
54.8 (22.7) 100 (31) 100 (14/14) |
20.0 (29.7) 36.7 (11) 46.2 (6/13) |
| PPD ≥6 mm + BoP/SoP (same site) |
% of sites (SD) % of implants (n) % of patients (n) |
50.0 (27.8) 100 (22) 100 (14/14) |
8.8 (20.3) 20.0 (4) 33.3 (4/12) |
41.1 (24.6) 90.3 (28) 100 (14/14) |
17.5 (28.7) 33.3 (10) 46.2 (6/13) |
Table 4 Descriptive statistics of clinical parameters
Serial posts:
- Abstract : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Background : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [1]
- Background : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [2]
- Methods : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [1]
- Methods : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [2]
- Methods : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [3]
- Results : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Discussion : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [1]
- Discussion : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [2]
- Discussion : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [3]
- Conclusions : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Abbreviations : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- References : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [1]
- References : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [2]
- References : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [3]
- References : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [4]
- Author information : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [1]
- Author information : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT [2]
- Ethics declarations : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Rights and permissions : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- About this article : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Table 1 Characteristics of included patients/implants : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Table 2 Log-transformed mean bacterial anaerobic counts (SD) of culture-positive implants for the control and test group before (Tpre) and after (Tpost) debridement and decontamination of the implant surface (intra-operative microbrush samples) : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Table 3 Log-transformed mean bacterial anaerobic counts (SD) for the control and test group before (T0) and 3 months after (T3) the surgical treatment (paperpoint samples) : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Table 4 Descriptive statistics of clinical parameters : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up : Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
- Fig. 1. Flow diagram : Implant decontamination with phosphoric acid during surgical peri-implant